So now we are 12 months behind the milestones advised at the 2020 AGM and the 20 Oct 2020 Presentation for the equity raising
I get as annoyed as anyone at slipping timelines but I’m not sure why you think that the program has slipped back by 12 months since October/November last year.
This is from the announcement today
Larger animal studies for VP-001 have commenced on schedule in Q2 2021 and will continue throughout Q3 2021
Subsequent to the GLP studies, PYC anticipates submitting an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) in mid-2022 before commencing clinical development
And these were the milestones advised in the equity raising presentation and at the AGM last year
To me, it looks like the lead program is roughly a quarter behind. Of course, we are yet to see if a mid-2022 IND submission transpires.
- Forums
- ASX - By Stock
- PYC
- Ann: Commencement of Larger Animal Studies for Lead Program
Ann: Commencement of Larger Animal Studies for Lead Program, page-6
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
12.0¢ |
Change
0.005(4.35%) |
Mkt cap ! $559.9M |
Open | High | Low | Value | Volume |
12.0¢ | 12.5¢ | 12.0¢ | $279.9K | 2.315M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 147929 | 12.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.5¢ | 834773 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 147929 | 0.120 |
13 | 978136 | 0.115 |
11 | 663187 | 0.110 |
13 | 1606450 | 0.105 |
15 | 1401739 | 0.100 |
Price($) | Vol. | No. |
---|---|---|
0.125 | 834773 | 5 |
0.130 | 397621 | 3 |
0.135 | 750295 | 4 |
0.140 | 756230 | 8 |
0.145 | 443572 | 9 |
Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |